Latest News

IL-17 Pathway Linked to HIF-1-alpha Activation in Psoriasis
IL-17 Pathway Linked to HIF-1-alpha Activation in Psoriasis

May 22nd 2024

Researchers from NYU Langone recently published a study clarifying the role of HIF-1-alpha in inflammation and psoriasis, which has been unclear until now.

Dose Escalation of Biologic PsO Treatment in Japan
Dose Escalation of Biologic PsO Treatment in Japan

May 21st 2024

Ayesha Patrick: Advocacy, Representation, and Hope Via AbbVie's Clearly Me Campaign
Ayesha Patrick: Advocacy, Representation, and Hope Via AbbVie's Clearly Me Campaign

May 21st 2024

Photographer Behind AbbVie's Clearly Me Campaign for Amplifying Voices of Psoriasis Speaks to Advocacy, Awareness
Photographer Behind AbbVie's Clearly Me Campaign for Amplifying Voices of Psoriasis Speaks to Advocacy, Awareness

May 17th 2024

Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial
Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial

May 16th 2024

© 2024 MJH Life Sciences

All rights reserved.